Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Vet Clin North Am Small Anim Pract ; 52(3): 609-629, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35379500

RESUMEN

Symmetric dimethylarginine (SDMA) is a valuable surrogate marker for decreased glomerular filtration rate (GFR) and is incorporated into the International Renal Interest Society (IRIS) guidelines for diagnosing, staging, and treating chronic kidney disease (CKD). SDMA increases above the reference interval with smaller reductions in GFR rate than does creatinine and persistent mild increases in SDMA can be used to diagnose early-stage CKD. Evaluation of both SDMA and creatinine is recommended for diagnosis and monitoring of animals with CKD.


Asunto(s)
Enfermedades de los Gatos , Enfermedades de los Perros , Insuficiencia Renal Crónica , Animales , Arginina/análogos & derivados , Biomarcadores , Enfermedades de los Gatos/diagnóstico , Gatos , Creatinina , Enfermedades de los Perros/diagnóstico , Perros , Femenino , Riñón , Masculino , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/veterinaria
2.
Vet Rec ; 187(10): e82, 2020 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-32611706

RESUMEN

BACKGROUND: Kidney disease, especially chronic kidney disease (CKD), is common in older dogs. The biomarkers symmetric dimethylarginine (SDMA) and creatinine (Cr) are indicators of glomerular filtration rate (GFR). This retrospective study used these biomarkers to identify groups at risk of decreased GFR at the breed level. METHODS: Data from dogs with a single serum chemistry result that included Cr and SDMA submitted between July 2015 through December 2017 were included. Dogs were identified by breed and age group. Decreased GFR was defined as Cr above 1.9 mg/dl or SDMA above 18 µg/dl. RESULTS: Fourteen breeds had a significantly higher percentage of dogs with increased SDMA or Cr for one or more age groups. Geriatric and senior Shetland sheepdogs, Yorkshire terriers and Pomeranians were significantly more likely to have increased renal biomarkers. Boxers were identified with significantly increased renal biomarkers in the age groups spanning two months to 10 years of age. CONCLUSION: Evidence of decreased GFR occurred commonly in older dogs of most breeds, especially geriatric dogs greater than 10 years of age, but there were some exceptions, with more significant changes affecting younger animals of several breeds. The combination of SDMA and Cr identified more cases of decreased GFR than either SDMA or Cr alone.


Asunto(s)
Arginina/análogos & derivados , Creatinina/sangre , Insuficiencia Renal Crónica/veterinaria , Factores de Edad , Animales , Arginina/sangre , Biomarcadores/sangre , Enfermedades de los Perros/sangre , Enfermedades de los Perros/diagnóstico , Perros , Tasa de Filtración Glomerular/veterinaria , Linaje , Insuficiencia Renal Crónica/diagnóstico , Estudios Retrospectivos , Factores de Riesgo
3.
PLoS One ; 15(1): e0227964, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31990929

RESUMEN

Hyperthyroidism in cats can mask changes in renal function, including chronic kidney disease (CKD), because of hyperfiltration and muscle loss. Symmetric dimethylarginine (SDMA) has been shown to increase earlier than creatinine in cats with renal dysfunction, and, unlike creatinine, SDMA is not impacted by lean muscle mass. The aim of this study was to describe the relationship between SDMA, creatinine, body weight and TT4 over time during treatment of hyperthyroidism. Cats were retrospectively identified from the US IDEXX Reference Laboratories database where TT4, SDMA and creatinine were measured on the same cat at multiple time points. A hyperthyroid treated group was identified (TT4 ≤ 4.7 µg/dL and decreased by a minimum of 2.5 µg/dL) that had body weight and laboratory results available from more than one visit, and was used to evaluate body weight, creatinine, SDMA and TT4 pre-treatment and at 1-30, 31-60, 61-90, 91-120 days post-treatment. Creatinine significantly decreased with increasing concentrations of TT4 (Spearman's ρ = -0.37, P < 0.001), whereas SDMA did not. Body weight, SDMA and creatinine concentrations significantly increased during the immediate 1-30 day post-treatment period (P < 0.012, P < 0.001, P < 0.001, respectively). During treatment creatinine continued to increase as cats gained weight. In contrast, SDMA remained stable during treatment and was comparable to age-matched control cats. Therefore, SDMA may be a more reliable biomarker of renal function than creatinine in hyperthyroid cats before and during treatment.


Asunto(s)
Arginina/análogos & derivados , Creatinina/sangre , Hipertiroidismo/sangre , Insuficiencia Renal Crónica/sangre , Animales , Arginina/sangre , Biomarcadores/sangre , Peso Corporal/fisiología , Gatos , Pruebas Diagnósticas de Rutina , Femenino , Tasa de Filtración Glomerular/fisiología , Hipertiroidismo/patología , Hipertiroidismo/veterinaria , Riñón/metabolismo , Riñón/patología , Masculino , Insuficiencia Renal Crónica/patología , Insuficiencia Renal Crónica/veterinaria , Estudios Retrospectivos
4.
PLoS One ; 13(10): e0205030, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30321185

RESUMEN

Kidney disease is common in companion animals, and traditionally diagnosed with serum creatinine concentration (sCr), blood urea nitrogen, and abnormal urinalysis findings. Symmetric dimethylarginine (SDMA) is a novel kidney biomarker that reflects glomerular filtration rate, increasing earlier than sCr with acute kidney injury and chronic kidney disease. This prospective study compared accuracy and precision of two commercial SDMA assays, the IDEXX SDMA Test and the DLD SDMA ELISA, relative to the established reference method, liquid chromatography/mass spectrometry (LC-MS). Thirty canine and 30 feline pooled serum samples were used to evaluate accuracy compared to LC-MS. Pooled canine samples with a low SDMA concentration and pooled feline samples with a high SDMA concentration were used to evaluate precision. Using a best fit linear model, the IDEXX SDMA Test resulted in a slope of 1.06 and an intercept of 0.34, with R2 = 0.99, and the DLD SDMA ELISA resulted in a slope of 0.37 and an intercept of 11.33, with R2 = 0.27, when compared to LC-MS. Estimated bias over a clinically relevant range for SDMA (10-45 µg/dL) was 1-2 µg/dL for the IDEXX SDMA Test, while DLD SDMA ELISA showed considerable bias, 5-8 µg/dL. Day-to-day precision analysis of the low SDMA concentration samples showed 7.7% total coefficient of variation (CV) for the IDEXX SDMA Test and 31.1% for the DLD SDMA ELISA. For the high SDMA concentration samples, total CV was 2.3% for the IDEXX SDMA Test and 28.2% for the DLD SDMA ELISA. In this study the IDEXX SDMA Test was more accurate and more precise in macroscopically normal serum than the DLD SDMA ELISA when compared to the reference method of LC-MS. The IDEXX SDMA Test is more suitable for clinical use in the diagnosis and monitoring of kidney disease in dogs and cats.


Asunto(s)
Arginina/análogos & derivados , Ensayo de Inmunoadsorción Enzimática , Espectrometría de Masas en Tándem , Animales , Arginina/sangre , Gatos , Cromatografía Líquida de Alta Presión , Perros , Modelos Lineales , Estudios Prospectivos , Juego de Reactivos para Diagnóstico , Reproducibilidad de los Resultados
5.
Vet Clin North Am Small Anim Pract ; 46(6): 941-60, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27499007

RESUMEN

Chronic kidney disease (CKD) is a common condition in cats and dogs, traditionally diagnosed after substantial loss of kidney function when serum creatinine concentrations increase. Symmetric dimethylarginine (SDMA) is a sensitive circulating kidney biomarker whose concentrations increase earlier than creatinine as glomerular filtration rate decreases. Unlike creatinine SDMA is unaffected by lean body mass. The IDEXX SDMA test introduces a clinically relevant and reliable tool for the diagnosis and management of kidney disease. SDMA has been provisionally incorporated into the International Renal Interest Society guidelines for CKD to aid staging and targeted treatment of early and advanced disease.


Asunto(s)
Arginina/análogos & derivados , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Perros/diagnóstico , Insuficiencia Renal Crónica/sangre , Animales , Arginina/sangre , Biomarcadores/sangre , Enfermedades de los Gatos/sangre , Gatos , Enfermedades de los Perros/sangre , Perros , Insuficiencia Renal Crónica/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA